Highlands Oncology Group-Research Department ( Site 0133) — Springdale, Arkansas

Highlands Oncology Group-Research Department ( Site 0133) is a clinical research site located in Springdale, Arkansas, United States 72762.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Highlands Oncology Group-Research Department ( Site 0133) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group-Research Department ( Site 0133)?

Highlands Oncology Group-Research Department ( Site 0133) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group-Research Department ( Site 0133) conducted?

Highlands Oncology Group-Research Department ( Site 0133) has 1 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma.

Is Highlands Oncology Group-Research Department ( Site 0133) accredited by Crixeo Health?

Highlands Oncology Group-Research Department ( Site 0133) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Highlands Oncology Group-Research Department ( Site 0133)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.